Loading insider details...
Latest Form 4 (Oct 28, 2025): Tender of Shares of 518 TRML shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 28, 2025 | Tourmaline Bio, Inc. (TRML) | Tender of Shares | 518 | n/a |
| Jun 6, 2025 | Tourmaline Bio, Inc. (TRML) | Grant/Award | 16,800 | n/a |
| Jun 7, 2024 | Tourmaline Bio, Inc. (TRML) | Grant/Award | 10,000 | n/a |
| Jan 31, 2024 | Tourmaline Bio, Inc. (TRML) | Purchase | 100,000 | $3.25M |
| Oct 24, 2023 | Tourmaline Bio, Inc. (TRML) | Grant/Award | 348,431 | n/a |
| Jun 14, 2023 | Talaris Therapeutics, Inc. (TALS) | Grant/Award | 20,500 | n/a |
| Apr 11, 2023 | Jasper Therapeutics, Inc. (JSPR) | Purchase | 2,666,666 | $4.00M |
| Jun 13, 2022 | Talaris Therapeutics, Inc. (TALS) | Grant/Award | 14,501 | n/a |